Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1674111B1 Anti-glypican 3 antibody
11/03/2010EP1617858B1 Caspase 3, 8, 9 or 10 inhibitors in combination with MEK inhibitors for the treatment of influenza
11/03/2010EP1606232B1 Improved extraction process
11/03/2010EP1602720B1 Process for producing heterologous protein in e. coli
11/03/2010EP1599496B1 Hepatitis c inhibitor peptide analogs
11/03/2010EP1478664B1 Tissue specific expression
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1261718B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/03/2010EP1076662B1 Polyepitope carrier protein
11/03/2010EP0912734B1 Chimeric heteromultimer adhesins
11/03/2010EP0568575B2 Test and model for alzheimer's disease
11/03/2010CN1244215B Improved method for the production and purification of adenoviral vectors
11/03/2010CN101878302A Pseudomonas aeruginosa outer membrane protein PA4710
11/03/2010CN101878226A New synthetic arginine substituted peptides and their use
11/03/2010CN101878225A New BNP(1-32) epitope and antibodies directed against said epitope
11/03/2010CN101878224A Erythropoietin
11/03/2010CN101878223A Methods of treating cancer using NOTCH pathway inhibitors
11/03/2010CN101878222A AXMI-066 and AXMI-076: delta-endotoxin proteins and methods for their use
11/03/2010CN101878038A Engineered pertactin variants for vaccine use
11/03/2010CN101877961A Use of neuregulin for organ preservation
11/03/2010CN101876660A Simian foamy virus recombinant antigen ELISA (Enzyme-Linked Immunosorbent Assay) detection method and reagent kit
11/03/2010CN101875939A Rhizobiaceae gene and polypeptide and application
11/03/2010CN101875693A Albumin variant having anti-angiogenesis activity and preparation method thereof
11/03/2010CN101875692A Chinese hamster apoptosis-related genes
11/03/2010CN101875691A Scorpion arialgesic antitumoral peptide mutant and preparation method thereof
11/03/2010CN101875690A Rice gene OsWRKY78 and application thereof
11/03/2010CN101875689A New gene for rice zinc-finger protein transcription factor and application thereof to drought resistance and salt tolerance
11/03/2010CN101555479B Moss expressing promoting regions
11/03/2010CN101451141B Avirulence gene avrxa5 capable of stimulating rice to generate disease resistance response
11/03/2010CN101429510B Wheat hpfw gene, expression product and uses thereof
11/03/2010CN101302517B Expressing method of human interleukin 7 in eucaryon host
11/03/2010CN101260153B Human breast carcinoma tissue antigen, and coding gene, preparation method and application thereof
11/03/2010CN101245345B Goat S6K1 gene cDNA encoding zone nucleotide sequence
11/03/2010CN101215330B Method for preparing 1-aminohydantoin artificial antigen
11/03/2010CN101104635B Method for purifying recombination human alpha-whey albumin from transgene cow milk
11/03/2010CN101092628B Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
11/03/2010CN101037696B Paddy cool injury gene and application
11/03/2010CN100999553B HR2 analogous protein and its coding gene and application
11/02/2010US7825296 Transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor; improved resistance to cold, heat, freezing, low nitrogen and phosphorus conditions, osmotic stresses such as drought, and high salt
11/02/2010US7825295 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
11/02/2010US7825293 Plants having improved growth characteristics and a method for making the same
11/02/2010US7825292 Hamster model comprising muscle protein mutation for use in treatment and prevention of cardiovascular disorders
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825226 Pharmacokinetics; glycosyltransferases
11/02/2010US7825220 Growth suppressor protein-1 (Gros1) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825218 Solubilization and purification of a target protein fused to a mutant maltose-binding protein
11/02/2010US7825097 Nucleotide vector vaccine for immunization against hepatitis
11/02/2010US7825093 Methods of using OSK1 peptide analogs
11/02/2010US7825089 Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
11/02/2010US7825085 Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells
11/02/2010US7825083 Synovial fluid barrier
11/02/2010US7824923 Screening for drugs which alter the amount, localization and/or characteristics of differentiation factors; use in enhancing the memory performance
11/02/2010US7824908 Expression vector comprising nucleotide sequences coding toxoplasma major surface antigen p30 for use in generation of immunoglobulin for use in prevention and treatment of parasitic infection
11/02/2010US7824907 Expression vectors comprising the mCMV IE2 promoter
11/02/2010US7824898 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control
11/02/2010US7824895 Phytases, nucleic acids encoding them and methods for making and using them
11/02/2010US7824894 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
11/02/2010US7824869 Apoproteins; membrane proteins; high throughput screening
11/02/2010US7824866 Polyunsaturated fatty acids; kits
11/02/2010US7824860 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
11/02/2010US7824851 With purine or pyrimidine base; for use in combination with drugs that induce mutation in Flaviviridae at location other than mutation of nucleotide that results in change from serine to a different amino acid in highly conserved consensus sequence XRXSGXXXT of domain B of the RNA polymerase region
11/02/2010US7824850 Methods of protein destabilization and uses thereof
11/02/2010US7824695 recombinant proteins comprise cell recognition moiety that binds alpha 2 macroglobulin receptor, and bioactive moiety (pseudomonas exotoxin), which mediates systemic effect, does not function as immunogen and does not have ADP ribosylating activity
11/02/2010US7824692 homologous immunoreactive thio-disulfide oxidoreductases; fusion proteins; fluorescent, radioactive, or enzymatic labels
11/02/2010US7824689 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus
11/02/2010US7824688 Glucan-based vaccines
11/02/2010US7824687 Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
11/02/2010US7824676 Immunoglobulin specific to junction-enriched and -associated proteins (JEAP) for use in identifying proteins localized at cell-to-cell junctions; fluorescence-labeled protein localization
11/02/2010US7824669 administering a composition comprising a GM-CSF cysteine mutein of SEQ ID NO:8, wherein a cysteine residue is substituted for an amino acid selected from the group consisting of A1, A3, S5, S7, N27, T32, A33, E51, R67, S69, E93, T94, T98, Q99, T102, E123, V125, Q126, and E127
11/02/2010CA2596977C Pyy agonists and uses thereof
11/02/2010CA2510717C Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
11/02/2010CA2509063C Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases
11/02/2010CA2467359C Electroprocessed collagen
11/02/2010CA2459690C Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
11/02/2010CA2450581C Cardiovascular safety assay
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2406100C Dna transfection system for the generation of infectious influenza virus
11/02/2010CA2360252C Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
11/02/2010CA2339641C Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof
11/02/2010CA2265989C Methods for in vitro determination of erythropoietin bioactivity
11/02/2010CA2253246C Purified multimerase
11/02/2010CA2181394C Ctla4 mutant molecules and uses thereof
11/02/2010CA2150555C Cloning and expression of biologically active alpha-galactosidase a
11/02/2010CA1341608C Promoters of filamentous fungi and use thereof
11/02/2010CA1341607C Production of erythropoietin
11/01/2010CA2665302A1 Cd36 modulation and uses thereof
10/2010
10/28/2010WO2010124259A1 Allosteramers for tnf receptors and uses thereof
10/28/2010WO2010124256A2 Methods and systems for identifying immunomodulatory substances
10/28/2010WO2010124226A2 Toll-like receptor-based biosensors
10/28/2010WO2010124142A2 Cell compositions derived from dedifferentiated reprogrammed cells
10/28/2010WO2010124010A1 Microparticle organization
10/28/2010WO2010123813A1 Immunogenic epitopes of ngep antigen
10/28/2010WO2010123519A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010WO2010123450A1 Method of producing polymers of spider silk proteins
10/28/2010WO2010123386A1 Method of preparing low-iron lactoferrin
10/28/2010WO2010123350A1 Regulators involved in mushroom formation
10/28/2010WO2010123290A2 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
10/28/2010WO2010123180A1 Pancreas tissue specific gene mmp1
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 2916